Anandamide induces endothelium-dependent vasoconstriction and CGRPergic nerve-mediated vasodilatation in the rat mesenteric vascular bed

Journal of Pharmacological Sciences

Volumn 118, Issue 4, 2012, Pages 496-505

  Tamaki, Chihiro ^a   Nawa, Hideki ^b   Takatori, Shingo ^a   Oda, Sakiko ^a   Sendo, Toshiaki ^b   Zamami, Yoshito ^a   Kawasaki, Hiromu ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Anandamide; Cannabinoid 1 receptor; CGRPergic nerve; Prostanoid; Transient receptor potential vanilloid 1

Indexed keywords

ANANDAMIDE; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; CAPSAZEPINE; INDOMETACIN; OXIDOPAMINE; RIMONABANT;

ADRENERGIC NERVE; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYOPRESERVATION; DENERVATION; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; MALE; MESENTERY BLOOD FLOW; NONHUMAN; PERFUSION PRESSURE; PRESSURE MEASUREMENT; RAT; SENSITIVITY ANALYSIS; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

EID: 84867192990     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11236FP     Document Type: Article

References (48)

1. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346:561-564.
2. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365:61-65.
3. Bonz A, Laser M, Küllmer S, Kniesch S, Babin-Ebell J, Popp V, et al. Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle. J Cardiovasc Pharmacol. 2003;41:657-664.
4. Deutsch DG, Goligorsky MS, Schmid PG, Krebsbach RJ, Schmid RJ, Das SK, et al. Production and physiological actions of anandamide in the rat kidney. J Clin Invest. 1997;100:1538-1546.
5. Liu J, Gao B, Mirshahi F, Sanyal AJ, Khanolkar AD, Makriyannis A, et al. Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem J. 2000;15:835-840.
6. 2+ channel current. Am J Physiol Heart Circ. 1999;276:H2085-H2093.
7. Ibrahim MM, Deng H, Zvonok A, Cockayne DA, Kwan J, Mata HP, et al. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci U S A. 2003;100:10529-10533.
8. Quartilho A, Mata HP, Ibrahim MM, Vanderah TW, Porreca F, Makriyannis A, et al. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology. 2003;99:955-960.
9. Walter L, Stella N. Cannabinoids and neuroinflammation. Br J Pharmacol. 2004;141:775-785.
10. Yoshihara S, Morimoto H, Ohori M, Yamada Y, Abe T, Arisaka O. The cannabinoid receptor agonist WIN 55212-2 inhibits neurogenic inflammations in airway tissues. J Pharmacol Sci. 2005;98:77-82.
11. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. Isolated and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258:1946-1949.
12. Randall MD, Alexander SP, Bennett T, Boyd EA, Fry JR, Gardiner SM, et al. An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Commun. 1996;229:114-120.
13. Lake KD, Martin BR, Kunos G, Varga K. Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension. 1997;29:1204-1210.
14. Gardiner SM, March JE, Kemp PA, Bennett T. Complex regional haemodynamic effects of anandamide in conscious rats. Br J Pharmacol. 2002;135:1889-1896.
15. Bátkai S, Pacher P, Osei-Hyaman D, Radaeva S, Liu J, Harvey-White J, et al. Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation. 2004;110:1996-2002.
16. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science. 1999; 283:401-404.
17. Pratt PF, Hillard CJ, Edgemond WS, Campbell WB. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Am J Physiol Heart Birc. 1998;274:H375-H381.
18. Wagner JA, Varga K, Járai Z, Kunos G. Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension. 1999;33:429-434.
19. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Søgård M, Di Marzo V, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 1999;400:452-457.
20. Ho WS, Hiley CR. Endothelium-independent relaxation to cannabinoids in rat-isolated mesenteric artery and role of Ca2+ influx. Br J Pharmacol. 2003;139:585-597.
21. Randall MD, McCulloch AI, Kendall DA. Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery. Eur J Pharmacol. 1997;333:191-197.
22. Randall MD, Kendall DA. Anandamide and endothelium-derived hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery. Eur J Pharmacol. 1998;346:51-53.
23. Grainger J, Boachie-Ansah G. Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels. Br J Pharmacol. 2001;134:1003-1012.
24. Herradón E, Martín MI, López-Miranda V. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta. Br J Pharmacol. 2007;152:699-708.
25. Barbosa PPP, Lapa AJ, Lima-Landman MT, Valle JR. Vasoconstriction induced by Δ9-tetrahydrocannabinol on perfused rabbit ear artery. Arch Int Pharmacodyn. 1981;252:253-261.
26. Varga K, Lake KD, Martin BR, Kunos G. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol. 1995;278:279-283.
27. Kawasaki H, Takasaki K, Saito A, Goto K. Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature. 1988;335:164-167.
28. Kawasaki H, Nuki C, Saito A, Takasaki K. NPY modulates neurotransmission of CGRP-containing vasodilator nerves in rat mesenteric arteries. Am J Physiol. 1991;261:H683-H690.
29. Takenaga M, Kawasaki H, Wada A, Eto T. Calcitonin gene-related peptide mediates acetylcholine-induced endothelium-independent vasodilation in mesenteric resistance blood vessels of the rat. Circ Res. 1995;76:935-941.
30. Zhang W, Edvisson L, Lee TJ. Mechanism of nicotine-induced relaxation in the porcine basilar artery. J Pharmacol Exp Ther. 1998;284:790-797.
31. Kawasaki H, Nuki C, Saito A, Takasaki K. Role of calcitonin gene-related peptide-containing nerves in the vascular adrenergic neurotransmission. J Pharmacol Exp Ther. 1990;252:403-409.
32. Shiraki H, Kawasaki H, Tezuka S, Nakatsuma A, Kurosaki Y. Endogenous calcitonin gene-related peptide (CGRP) mediates adrenergic-dependent vasodilation induced by nicotine in mesenteric resistance arteries of the rat. Br J Pharmacol. 2000;130:1083-1091.
33. Jin X, Satoh-Otonashi Y, Zamami Y, Hobara N, Koyama T, Sun P, et al. Age-related disappearance of the inhibitory effect of vascular endothelium on agonist-induced vasoconstriction in rat mesenteric vascular beds. J Pharmacol Sci. 2009;111:372-380.
34. Kawasaki H, Takasaki K. Vasoconstrictor response induced by 5-hydroxytryptamine released from vascular adrenergic nerves by periarterial nerve stimulation. J Pharmacol Exp Ther. 1984;229:816-822.
35. Takenaga M, Kawasaki H. Endogenous calcitonin gene-related peptide suppresses vasoconstriction mediated by adrenergic nerves in rat mesenteric resistance blood vessels. Eur J Pharmacol. 1999;367:239-245.
36. Zygmunt PM, Högestätt ED, Waldeck K, Edwards G, Kirkup AJ, Weston AH. Studies on the effects of anandamide in rat hepatic artery. Br J Pharmacol. 1997;122:1679-1686.
37. O'Sullivan SE, Kendall DA, Randall MD. Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries. Br J Pharmacol. 2004;142:435-442.
38. Chen P, Hu S, Yao J, Moore SA, Spector AA, Fang X. Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium. Microvasc Res. 2005;69:28-35.
39. 9- tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide. Br J Pharmacol. 2005;145:514-526.
40. Poblete IM, Orliac ML, Briones R, Adler-Graschinsky E, Huidobro-Toro JP. Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed. J Physiol. 2005;568:539-551.
41. Bevan JA, Brayden JE. Nonadrenergic neuronal vasodilator mechanism. Circ Res. 1987;60:309-326.
42. Toda N, Okamura T. Mechanism of neurally induced monkey mesenteric artery relaxation and contraction. Hypertension. 1992;19:161-166.
43. Lee TJ, Sarwinski S, Ishine T, Lai CC, Chen FY. Inhibition of cerebral neurogenic vasodilation by L-glutamine and nitric oxide synthase inhibitors and its reversal by L-citrulline. J Pharmacol Exp Ther. 1996;276:353-358.
44. Hatanaka Y, Hobara N, Honghua J, Akiyama S, Nawa H, Kobayashi Y, et al. Neuronal nitric-oxide synthase inhibition facilitates adrenergic neurotransmission in rat mesenteric resistance arteries. J Pharmacol Exp Ther. 2006;316:490-497.
45. Fujimori A, Saito A, Mimura S, Watanabe T, Uchiyama Y, Kawasaki H, et al. Neurogenic vasodilator and release of calcitonin gene-related peptide (CGRP) from perivascular nerve from the rat mesenteric artery. Biochem Biophys Res Commun. 1989;165:1391-1398.
46. Eguchi S, Tezuka S, Hobara N, Akiyama S, Kurosaki Y, Kawasaki H. Vanilloid receptors mediate adrenergic nerve- and CGRP-containing nerve-dependent vasodilation induced by nicotine in rat mesenteric resistance arteries. Br J Pharmacol. 2004;142:1137-1146.
47. Ahluwalia J, Urban L, Bevan S, Nagy I. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur J Neurosci. 2003;17:2611-2618.
48. Ishac EJ, Jiang L, Lake KD, Varga K, Abood ME, Kunos G. Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br J Pharmacol. 1996;118:2023-2028.